* Progyny Inc PGNY.OQ PGNY.O is expected to show a rise
in
quarterly revenue when it reports results on May 9 for the
period ending March 31 2024
* The New York City-based company is expected to report a
12.0% increase in revenue to $289.457 million from $258.39
million a year ago, according to the mean estimate from 9
analysts, based on LSEG data.The company's guidance on February
27 2024, for the period ended March 31, was for revenue between
$285.00 million and $292.00 million.
* LSEG's mean analyst estimate for Progyny Inc is for
earnings of
13 cents per share. The company's EPS guidance on February 27
2024, for the period ended March 31, was between $0.12 and
$0.13
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 9.4%
in the last three months.
* Wall Street's median 12-month price target for Progyny Inc
is
$46.00, above its last closing price of $33.06.
The company's guidance on February 27 2024 for the period ended
March 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of between USD285 million and USD51 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 0.12 0.11 0.13 Beat 21.5
Sep. 30 2023 0.12 0.12 0.16 Beat 36.6
Jun. 30 2023 0.11 0.10 0.15 Beat 43.8
Mar. 31 2023 0.07 0.07 0.18 Beat 142.3
Dec. 0.02 0.01 0.03 Beat 157.1
31 2022
Sep. 30 2022 0.06 0.05 0.13 Beat 175.8
Jun. 30 2022 0.02 0.05 0.09 Beat 100
Mar. 31 2022 0.00 0.01 0.05 Beat 525
This summary was machine generated May 8 at 02:04 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)